Combination Therapy in Pulmonary Arterial Hypertension: Is This the New Standard of Care?
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD
4
SENTRY Trial Shows Survival, Spleen Benefits in Myelofibrosis: Claire Harrison, MD
5